Heal thyself: Acelity Holdings files for an IPO that could raise $1 billion

Acelity Holdings, a global medical technology company developing advanced wound care and regenerative medicine, filed on Wednesday with the SEC to raise up to $100 million in an initial public offering. However, the deal size is likely a placeholder for an IPO that we estimate could raise up to $1 billion.

The San Antonio, TX-based company, which was founded in 2015 and booked $1.9 billion in sales for the 12 months ended June 30, 2015, plans to list on the New York Stock Exchange. J.P. Morgan, Goldman Sachs, BofA Merrill Lynch, Morgan Stanley, Barclays, Credit Suisse, RBC Capital Markets and UBS Investment Bank are the joint bookrunners on the deal. No pricing terms were disclosed.